Financials
- Market Capitalization 50.66 M
- Employee 9
- Founded 2014
- CEO N/A
- Website www.hyperiondefi.com
- Headquarter Delaware, United States
- FIGI BBG00JKZRCH4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.76
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4249 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.00 USD | +0.90% | -3.43% | 0.00% | +1204.35% | 52.04 M USD | ||
| 4257 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.11 USD | +3.23% | +13.30% | +5.14% | -37.91% | 50.80 M USD | ||
| 4282 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.75 USD | 0.00% | -5.06% | -3.85% | -58.33% | 47.63 M USD | ||
| 4294 | CELU Celularity Inc. - Class A Common Stock | 1.58 USD | -24.76% | +105.19% | +122.54% | -49.03% | 45.73 M USD |